Epstein Secrets

oderate or marked Titer Specimen ID: 104364919 Date Of Report: 09/80/2017 11:30 Date Collected:OE/30/2017 11:53 Date Received: 00/3e/2017 23:12 North America Eastern Time J Antibodies To Association Frequency ate Screening test for SLI In symptomatic patients. (Antinuclear Ab, 95.100% BioReference

L <150 ii7ac mg/dL Test Not Performed: Unable to perform HDL test due to elevated Triglycerides (>1290). INDL a rt:of diolesterol. TNP Y14 • Chol/HDL Ratio TNP <7.4 ilIDL/HDL' Ratio <3.56 COL'thOiesterol 'dee sox NOTE: Unable to calculate us. due to a Triglyceride level of greater than 400 mg/dL.

19158 A Date Of Report: 07/23/2016 M Date Collected: 07/20/2016 Time Collected: 08:52 i) Date Received: 07/20/2016 L Time Received: 23:20 C North America Eastern Time C_INICA'_ REPOt: Clinical Abnormalities Suarnary: ;may ra :ortaw ae aoname [ewes. eau ve toots may rot babe aonnat laps muse 'mew tome

ve toots may rot babe aonnat laps muse 'mew tome report) Creatinine 0.62 LO BUN/Creat Ratio Cholesterol 210 HI Triglycerides HDL as % of 13 Chol/HDL Ratio Cholesterol MDC 35.2 HI Hemoglobin A1c 5.9 HI 33.9 HI ALT 42 HI 950 HI HDL CHOL., DIRECT 28 LO 7.5 NON FASTING CHEMISTRY -t"' - .syk'i

(Notes: NON FASTING 1 Specimen ID: 102449709 Date Of Report: 01/28/2016 02:32 Date Collected: 01/27/2016 12:37 Date Received: 01/27/2016 23:01 North America Eastern Time CLINICAL REPORT Clinical Abnormalities Summary: (May not contain all abnormal results; narrative results may not have abnormal flags

10/27/2015 HDL CHOL., DIRECT 24 LO >40 mg/dL 29 LO 10/27/2015 HDL as % of Cholesterol 17 >14 % 14 * 10/27/2015 Evaluation: AVERAGE RISK Chol/HDL Ratio 6.0 <7.4 I 7.2 10/27/2015 Evaluation: AVERAGE RISK LDL/HDL Ratio Can't Calc <3.56 3.83 HI 10/27/2015 LDL Cholesterol Can't Calc <100 m

te Of Report:07/23/2016 E 71ST STREET Date Collected: 07/20/2016 NY 1x021 Time Collected: 08:52 Date Received: 07/20/2016 Time Received: 23:20 North America Eastern Time .." CLINICAL REPORT ."- . ,t,,; sfa :41 R , Bilirubin, Urine NEGATIVE NEGATIVE Blood, Urine NEGATIVE NEGATIVE Nitrites Urine

NEIL COL., DIRECT 28 LO >40 mg/dL 24 LO 01/27/2016 HDL as % of Cholesterol 13 Evaluation: ABOVE AV6.(MODERATE RISK) >14 X 17 01/27/2016 Chol/HDL Ratio 7.5 <7.4 6.0 01/27/2016 BioReference Laboratories, Inc. 481 Edward H. Ross Dr Elmwood Park, N7 07407 I (800) 2 9-5227 lames 4eisberger, Labo

or Dereatteyositis• IIIII Specimen ID: 104364919 Date Of Report: 09/08/2017 11:30 Date Collected:08/30/2017 11:58 Date Received: 08/30/2017 23:12 North America fasten, rime 6e -SON 40-78% 38.80% Antibodies to specific (Extractable) Nuclear Antigens (ENA)/Proteins dsONA Sm(Smith) SS A (R0) 55 8 (La)

mg/dL <150 ii7ac mn/OL Test Not Performed: Unable to perform HDL test due to elevated Triglycerides (>1290). INDL airtof diolesterol. TNP >14 Chol/HDL Ratio TNP <7.4 0.0L/HOL' Ratio TNP <3.56 ibLthblesterol cib't tile <100 sox NOTE: Unable to calculate LDL due to a Triglyceride level of greater

. N) 07407 PRELIMINARY Specimen ID: 104659439 Date Of Report: 09/19/2917 05:29 Date Collected: 09/15/2017 08:57 Date Received: 09/15/2017 23:06 North America Eastern 7itte JarnesWeiabergorld.D. Page 3 of 4 Laboratory Director Printed 09/19/2017 11:48 EFTA00299762 BioReference PRELIMINARY : Al:ORA

17 1RVAW:felY"' Cholesterol iTriayearides NOL CHOL., DIRECT MK as % of cholesterol 13 • >la •.• • it Evaluation: MOVE AVO.(PODERATE RISK) :Chol/HDL Ratio 7.7 • <7.4 Evaluation: ABOVE 4vG.(RODERATE RISK) rlDIVA0L Aiii0 " - 0.0L%Chelestendk . can't calc Can't Cili <100 <3.50 iiT&-- Cortrinta